Cargando…

341 Quality of Life in Pediatric Patients with Atopic Dermatitis

BACKGROUND: Atopic dermatitis (AD) is a common skin condition. The aim of this study was to evaluate the impact of AD on the quality of life of children and their families establishing correlations with scores of disease severity. METHODS: It was carried out an observational study of the correlation...

Descripción completa

Detalles Bibliográficos
Autor principal: Campos, Xiomara Lopez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512669/
http://dx.doi.org/10.1097/01.WOX.0000412104.57730.a4
_version_ 1782251774201036800
author Campos, Xiomara Lopez
author_facet Campos, Xiomara Lopez
author_sort Campos, Xiomara Lopez
collection PubMed
description BACKGROUND: Atopic dermatitis (AD) is a common skin condition. The aim of this study was to evaluate the impact of AD on the quality of life of children and their families establishing correlations with scores of disease severity. METHODS: It was carried out an observational study of the correlations between clinical indicators of severity and a questionnaire on quality of life: IDQOL. The study also included scoring of eczema severity – ISAAC. One hundred seventeen children with AD, fulfilling established diagnostic criteria, and 396 children with no dermatologic diseases were investigated for the effect of eczema on quality of life. Pearson's correlation was used for the correlation analysis and the comparison between the groups was carried out using the Mann-Whitney test. RESULTS: Data analysis demonstrated significant differences between the scores for the 2 groups. The mean score in the eczema group was 9.2 (range 1–19) for IDQOL. The highest scoring questions for IDQOL referred to itching and scratching, mood changes and problems caused by treatment. For the ISAAC, the highest impact domains were treatment-related expenditure and sleep disturbance affecting family members. CONCLUSIONS: AD has a negative impact on the quality of life of pediatric patients and their families. The individuals dealing with AD and their families need more than just the physical treatment of symptoms. Educational and psychological support for patients and their families in addition to medical treatment of AD may improve their long-term physical outcomes.
format Online
Article
Text
id pubmed-3512669
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher World Allergy Organization Journal
record_format MEDLINE/PubMed
spelling pubmed-35126692012-12-21 341 Quality of Life in Pediatric Patients with Atopic Dermatitis Campos, Xiomara Lopez World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: Atopic dermatitis (AD) is a common skin condition. The aim of this study was to evaluate the impact of AD on the quality of life of children and their families establishing correlations with scores of disease severity. METHODS: It was carried out an observational study of the correlations between clinical indicators of severity and a questionnaire on quality of life: IDQOL. The study also included scoring of eczema severity – ISAAC. One hundred seventeen children with AD, fulfilling established diagnostic criteria, and 396 children with no dermatologic diseases were investigated for the effect of eczema on quality of life. Pearson's correlation was used for the correlation analysis and the comparison between the groups was carried out using the Mann-Whitney test. RESULTS: Data analysis demonstrated significant differences between the scores for the 2 groups. The mean score in the eczema group was 9.2 (range 1–19) for IDQOL. The highest scoring questions for IDQOL referred to itching and scratching, mood changes and problems caused by treatment. For the ISAAC, the highest impact domains were treatment-related expenditure and sleep disturbance affecting family members. CONCLUSIONS: AD has a negative impact on the quality of life of pediatric patients and their families. The individuals dealing with AD and their families need more than just the physical treatment of symptoms. Educational and psychological support for patients and their families in addition to medical treatment of AD may improve their long-term physical outcomes. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512669/ http://dx.doi.org/10.1097/01.WOX.0000412104.57730.a4 Text en Copyright © 2012 by World Allergy Organization
spellingShingle Abstracts of the XXII World Allergy Congress
Campos, Xiomara Lopez
341 Quality of Life in Pediatric Patients with Atopic Dermatitis
title 341 Quality of Life in Pediatric Patients with Atopic Dermatitis
title_full 341 Quality of Life in Pediatric Patients with Atopic Dermatitis
title_fullStr 341 Quality of Life in Pediatric Patients with Atopic Dermatitis
title_full_unstemmed 341 Quality of Life in Pediatric Patients with Atopic Dermatitis
title_short 341 Quality of Life in Pediatric Patients with Atopic Dermatitis
title_sort 341 quality of life in pediatric patients with atopic dermatitis
topic Abstracts of the XXII World Allergy Congress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512669/
http://dx.doi.org/10.1097/01.WOX.0000412104.57730.a4
work_keys_str_mv AT camposxiomaralopez 341qualityoflifeinpediatricpatientswithatopicdermatitis